slides · global inventory
Sparkline
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 22,963
Current window 14,671-14,700
Pages 766
Rows per page 30
Arc
14,671-14,700 of 22,963
12
The flywheel diagram is a central visual component representing the core operational advantage.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
13
The slide uses QR codes to link to specific research papers.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
14
The slide uses a process flow framework to visualize the end-to-end drug development pipeline.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
15
The slide uses a process flow framework to explain the technical solution.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
16
The slide uses a process flow diagram to explain the technical methodology.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
17
The slide uses a split-screen layout to contrast the initial goals of the case study with the achieved outcomes.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
18
The slide uses a dot plot to show search space diversity and a bar chart to compare binding rates against various baselines.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
19
The slide demonstrates that Variant A* shows higher potency than the wild-type trastuzumab in both binding and ADCC assays.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Evidence1 hit
20
The slide uses a Gantt chart to illustrate the overlapping timelines of two batches of development.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Roadmap1 hit
21
The slide uses a process flow framework to show the progression from target discovery to optimized antibodies.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
22
The flywheel framework is explicitly labeled. The right side details the wet lab validation process.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
23
The slide highlights the challenge of binding affinity (Kd) for the beta variant (607 nM) compared to others, using molecular visualization of RBD mutations.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
24
The slide uses a process diagram to explain the technical methodology of Absci's drug discovery platform.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
25
The slide uses a process flow (1: Data generation, 2: Model training) followed by validation results (scatter plot and correlation table).Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
26
SPR stands for Surface Plasmon Resonance, a standard technique for measuring binding affinity.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
27
The slide uses a process diagram to explain the AI workflow and a table to show quantitative improvements in binding affinity (nM KD) for five different antibody candidates.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Traction1 hit
28
The slide uses a consistent visual metaphor of a central antibody binding to three distinct targets in each of the three columns.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
29
The slide uses a histogram to visualize the distribution of binding affinity (-log10(Kd)) for designed variants versus the wild-type baseline.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
30
The slide uses a hub-and-spoke visual metaphor to show a single antibody binding to multiple targets (human/mouse/cyno, isoforms, or viral variants).Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
31
The slide uses a process flow diagram to explain the core technology platform.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
34
The slide uses a split-screen layout to contrast two service offerings.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Go-to-market1 hit
35
Absci | Investor Presentation Deck | 42 slidesAbsci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Go-to-market1 hit
36
The slide uses a grid layout to present four distinct partnership case studies with testimonials.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Go-to-market1 hit
37
Uses a comparative timeline to illustrate process efficiency gains.Absci | Investor Presentation Deck | 42 slides · Absci
Pitch deck Investor relations Beat · Timeline1 hit
01
Includes branding for argenx and the ADDRESS study.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Attention1 hit
03
Uses an infinity loop diagram to represent a continuous process or cycle of learning.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Interest1 hit
04
The slide highlights the pharmacodynamic (PD) effect of background corticosteroids in the placebo group, which was unexpected.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · InterestLoop · Aha Moment1 hit
05
The slide uses a circular portrait montage to humanize the 'transformation' message.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
The slide presents a clinical trial outcome summary for the ADDRESS study.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The slide uses a process-oriented visual layout to map strategic pillars to specific operational achievements.argenx SE | Investor Presentation Deck | 9 slides · argenx
Conference presentation Investor relations Beat · Satisfaction1 hit